Plasmid News and Research

RSS
Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

DNA vaccine-induced antibodies neutralize SARS-CoV-2

DNA vaccine-induced antibodies neutralize SARS-CoV-2

The COVID-19 vaccine pipeline

The COVID-19 vaccine pipeline

Molecular mechanisms play key role in the development of healthy heart

Molecular mechanisms play key role in the development of healthy heart

Bacteria-free method for making SARS-CoV-2 infectious clones

Bacteria-free method for making SARS-CoV-2 infectious clones

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

Can amodiaquine short circuit this pandemic?

Can amodiaquine short circuit this pandemic?

Effective, simple, safe self-amplifying RNA vaccines

Effective, simple, safe self-amplifying RNA vaccines

A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines

A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines

Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial

Heat Biologics SARS-CoV-2 vaccine generates potent T cell response in pre-clinical trial

Discovery offers new hope for millions at risk from antibiotic-resistant infections

Discovery offers new hope for millions at risk from antibiotic-resistant infections

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

Influenza-virus-based vaccine platform another viable option against SARS-CoV-2

Synthetic riboregulators detect SARS-CoV-2 genome parts in 40 minutes

Synthetic riboregulators detect SARS-CoV-2 genome parts in 40 minutes

Touchlight, Cancer Research UK and University of Southampton team up to develop DNA cancer vaccine

Touchlight, Cancer Research UK and University of Southampton team up to develop DNA cancer vaccine

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Novel antibody test for SARS-CoV-2

Novel antibody test for SARS-CoV-2

Researchers perform first X-ray measurements on SARS-CoV-2 main protease

Researchers perform first X-ray measurements on SARS-CoV-2 main protease

Entos Pharmaceuticals selects two lead DNA vaccine candidates for COVID-19

Entos Pharmaceuticals selects two lead DNA vaccine candidates for COVID-19

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes

Structured 'cut-and-paste' design enables streamlined development of SARS-CoV-2 molecular probes